In vitro diagnostics needs seismic change
The current state of in vitro diagnostics (IVDs) is no longer fit for purpose. In vitro diagnostics needs seismic change to improve patient outcomes and deliver economic benefits.
Can cell therapy become cheaper and easier?
Cell and gene therapy is hailed as the future of 21st century medicine but is currently too expensive to be widely used. As a principal scientist in synthetic biology, Matthew Jones is part of a team addressing this issue in an ambitious project with exciting potential.
Real-time contamination detection for cell therapy manufacture
This whitepaper goes behind the scenes of a significant breakthrough for contamination detection in cell therapy monitoring. It tells the story of PureSentry, a prototype device for on-line, real-time detection.
Neuropathy screening from diabetic retinopathy images
People with diabetes have an increased risk of developing serious health problems, including neuropathy. We’ve developed an AI-based system, in partnership with eminent specialists, to assess the presence of neuropathy from retinal images.
Turning trash to cash: microalgae cultivation to mitigate environmental waste impact
‘Turning trash into cash’ provides opportunity for companies to gain first-mover advantage. We outline a method that be considered as a carbon capture method – but is more likely to yield valuable bio-derived compounds.